[Cardiovascular calcification inhibitors]

Ann Biol Clin (Paris). 2015 May-Jun;73(3):315-22. doi: 10.1684/abc.2015.1047.
[Article in French]

Abstract

Vascular calcification is a marker of cardiovascular risk increase. Age and specific disease such as diabetes or chronic kidney disease are important factors for calcification genesis. Vascular calcification process is a complex phenomenon, involving several activators and inhibitors factors. Indeed, recent works related to in vitro and in vivo experimental studies have led to a better understanding of calcification process and identification of molecules able to modulate this system. This revue will summarize some of these molecules with a particular interest of those with therapeutic relevance. We will present: i) calcium sensing receptor and its modulation by cinacalcet; ii) pyrophosphate supplementation; iii) fetuin A and overall propensity serum test for calcification and finally; iv) matrix-Gla-protein and the use of vitamin K to prevent vascular calcification progression.

Keywords: calcium sensing receptor; fetuin A; matrix Gla protein; pyrophosphate; vascular calcification.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Calcium-Binding Proteins / physiology
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Diphosphates / therapeutic use
  • Extracellular Matrix Proteins / physiology
  • Humans
  • Matrix Gla Protein
  • Vascular Calcification / etiology
  • Vascular Calcification / prevention & control*
  • alpha-2-HS-Glycoprotein / physiology

Substances

  • Calcium-Binding Proteins
  • Diphosphates
  • Extracellular Matrix Proteins
  • alpha-2-HS-Glycoprotein